An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective.

Int J Mol Sci · 2023 · PMC10418869 · PMID 37569269

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

4.2 months, HR = 0.32), and a positive trend was observed for BRCA-mutated patients (14.4 vs. 9.0 months, HR = 0.49).

also in 6,846 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.